Table 5. Lung cancer survival by characteristics among patients with solid nodules (n=1,587).
| Characteristics | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Sex (male vs. female) | 0.699 (0.521–0.937) | 0.017 | 0.681 (0.506–0.917) | 0.011 | |
| Age at diagnosis | 1.765 (1.334–2.337) | <0.001 | 1.696 (1.280–2.248) | <0.001 | |
| Smoking history | 1.270 (0.959–1.681) | 0.095 | |||
| Family history of cancer | |||||
| Family history of lung cancer | 0.925 (0.516–1.659) | 0.794 | |||
| Pathologic subtype | |||||
| LUAD | 1 | ||||
| LUSC | 1.209 (0.860–1.700) | 0.274 | |||
| LASC | 1.695 (0.862–3.334) | 0.126 | |||
| Others | 1.617 (0.961–2.720) | 0.070 | |||
| Carcinoma type | |||||
| LUAD | 1 | ||||
| Non-LUAD | 1.336 (0.997–1.789) | 0.052 | |||
| Clinical or pathological Stage | |||||
| IA | 1 | 1 | |||
| IB | 1.431 (1.045–1.958) | 0.025 | 1.156 (0.791–1.688) | 0.454 | |
| LVI | 1.155 (0.642–2.076) | 0.631 | |||
| VPI | 1.511 (1.140–2.003) | 0.004 | 1.467 (1.041–2.066) | 0.029 | |
LASC, lung adenosquamous carcinoma; LVI, lymphovascular invasion; LUAD, lung adenocarcinoma; LUSC, lung squamous carcinoma; VPI, visceral pleural invasion.